Pfizer Agrees To Let Other Companies Manufacture Its COVID-19 Pill

Pfizer Agrees To Let Other Companies Manufacture Its COVID-19 Pill

Assessment

Interactive Video

Science, Biology, Health

9th - 10th Grade

Hard

Created by

Wayground Content

FREE Resource

The video discusses a COVID-19 pill that could be available to over half the world's population. The pharmaceutical company will not charge royalties in low-income countries and will waive them where COVID-19 remains a public health emergency. The pill reportedly reduces hospitalization and death by 90% in mild and moderate cases. The company is awaiting federal authorization.

Read more

5 questions

Show all answers

1.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What is the potential global impact of the COVID-19 pill?

It will not be available globally.

It will be available to less than half the world population.

It will be available to more than half the world population.

It will only be available in high-income countries.

2.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What is the policy regarding royalties for the COVID-19 pill in low-income countries?

Royalties will be waived.

Royalties will be reduced by 50%.

Royalties will be doubled.

Royalties will remain the same.

3.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

Under what condition will royalties be waived for the COVID-19 pill?

When the pill is ineffective.

When the pill is federally authorized.

When the virus is still a public health emergency.

When the virus is no longer a public health emergency.

4.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

By what percentage does the COVID-19 pill reduce hospitalization and death rates in mild and moderate cases?

50%

70%

90%

100%

5.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What is the current status of the COVID-19 pill regarding federal authorization?

It has been fully authorized.

It is still waiting on federal authorization.

It has been rejected.

It is authorized only in some states.